MiR‐126 enhances the VEGF‐induced angiogenesis in SSc‐MVECs by targeting SPRED1 and PIK3R2, which are the negative regulator of Raf‐ERK and PI3K‐AKT signalling separately. This evidence concerns the gene PIK3R2 and systemic sclerosis.